Thorsten Stiewe

56PUBLICATIONS

170CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Genome structure and regulationEpigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (56)

Sort by Publication Date:

|Jul 12, 2026

Fragility of precision: resistance to mutant p53 reactivation.

|Apr 28, 2026

DARPins as pan-reactivators of temperature-sensitive p53 cancer mutants.

|Mar 25, 2026

Author Correction: Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses.

Oleg Timofeev, Boris Klimovich, Jean Schneikert

|Feb 26, 2026

Targeting the p53 cancer mutants Y220C, Y220N, and Y220S with the small-molecule stabilizer rezatapopt.

Danai Mavridi, Julianne S Funk, Dimitrios-Ilias Balourdas

|Feb 19, 2026

mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<sup>+</sup>/HER2<sup>-</sup> breast cancer.

Luise von Wichert, Alina Stroh, Marie Witt

|Feb 03, 2026

Secreted luciferases as a minimally invasive 3R-compliant tool for accurate monitoring of tumor burden.

Nastasja Merle, Imke Bullwinkel, Oleg Timofeev

Pageof 10

Frequent Collaborators

Rajkumar Savai

Andreas C Joerger

Julianne S Funk

Robert Liefke

Marek Bartkuhn

Niklas Gremke

Dimitrios-Ilias Balourdas

4 joint publications

Soni Savai Pullamsetti

3 joint publications

Werner Seeger

3 joint publications

Clara Simon

Frequent Collaborators

Rajkumar Savai

Andreas C Joerger

Julianne S Funk

Robert Liefke